Mounjaro KwikPen 5 mg
  1. Home
  2. Mounjaro
  3. Mounjaro KwikPen 5 mg

Mounjaro KwikPen 5 mg

Mounjaro KwikPen 5 mg is a prescription dual GIP and GLP-1 receptor agonist prefilled multi-dose injection pen used to improve glycemic control in adults with type 2 diabetes when combined with diet and exercise. It delivers 5 mg of tirzepatide by once-weekly subcutaneous injection and is commonly prescribed after the initial treatment phase. The KwikPen provides convenient, accurate, and reliable dose administration.

BUY NOW

Category

Mounjaro KwikPen 5 mg contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps improve blood glucose control by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The 5 mg strength is typically prescribed following the initial 2.5 mg starting dose as part of the recommended dose-escalation schedule to optimize therapeutic response. Manufactured under stringent pharmaceutical quality standards, the sterile multi-dose KwikPen is engineered for precise subcutaneous administration and dependable clinical performance. Mounjaro KwikPen 5 mg should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro KwikPen 5 mg
Active Ingredient Tirzepatide
Strength 5 mg
Dosage Form Multi-dose Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro KwikPen 5 mg, Tirzepatide 5 mg KwikPen, Mounjaro 5 mg Pen, Tirzepatide Injection Pen, GIP GLP-1 Injection Pen, Weekly Tirzepatide Pen, Multi-dose Tirzepatide Pen